Baird lowered the firm’s price target on Itron (ITRI) to $129 from $137 and keeps an Outperform rating on the shares. The firm updated its model following strong Q2 results but near-term uncertainty remains.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
- Itron Inc. Reports Strong Q2 2025 Financial Results
- Itron’s Strong Financial Performance and Growth Potential: A Buy Rating Despite Short-term Challenges
- JPMorgan upgrades Itron to Overweight, says ‘buy the dip’
- Itron upgraded to Overweight from Neutral at JPMorgan
- Itron reports Q2 EPS $1.62, consensus $1.33